Helicobacter  pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy

by Sotirios D. Georgopoulos, Vasilios Papastergiou, Stylianos Karatapanis
Published 2012-01-01

Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for <i>Helicobacter pylori</i> Eradication in High Clarithromycin Resistance Areas

by Sotirios D. Georgopoulos, Elias Xirouchakis, Christos Liatsos, Pericles Apostolopoulos, Panagiotis Kasapidis, Beatriz Martinez-Gonzalez, Fotini Laoudi, Maria Stoupaki, Georgios Axiaris, Dionysios Sgouras, Andreas Mentis, Spyridon Michopoulos
Published 2024-03-01

Evaluation of the Direct Economic Cost per Eradication Treatment Regimen against <i>Helicobacter pylori</i> Infection in Greece: Do National Health Policy-Makers Need to Care?

by Christos Liatsos, Apostolis Papaefthymiou, Nikolaos Kyriakos, Marios Giakoumis, Jannis Kountouras, Michail Galanopoulos, Periklis Apostolopoulos, Sotirios D. Georgopoulos, Christos Mavrogiannis, Aristomenis K. Exadaktylos, David Shiva Srivastava, Theodore Rokkas, Michael Doulberis
Published 2020-03-01

A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates

by Nikos Viazis, Konstantinos Argyriou, Katerina Kotzampassi, Dimitrios K. Christodoulou, Periklis Apostolopoulos, Sotirios D. Georgopoulos, Christos Liatsos, Olga Giouleme, Kanellos Koustenis, Christos Veretanos, Dimitris Stogiannou, Miltiadis Moutzoukis, Charalambos Poutakidis, Ioannis Ioardanis Mylonas, Ioulia Tseti, Gerassimos J. Mantzaris
Published 2022-02-01